A Safety and Efficacy Extension Study of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS) ClinicalTrials.gov, 14 Dec 2011 Accessed on 4 Jan 2012 from http://clinicaltrials.gov/ct2/show/NCT01226745. CommentRecommendBookmarkWatch